SCHEMBL667477

SCHEMBL667477

CN(C(=O)CCN)[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20915119 1.00 OPRM1 (0.31) OPRM1OPRD1
SCHEMBL26125983 0.93 CPB2 (0.33)
SCHEMBL26125613 0.93 CPB2 (0.33)
SCHEMBL5598753 0.90 GAA (0.36)
SCHEMBL28493057 0.87
SCHEMBL28498754 0.87
SCHEMBL22711564 0.85
SCHEMBL14362213 0.85
SCHEMBL10958803 0.84
SCHEMBL3847359 0.82 CPB2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675814-A1 COMPOSITION FOR TOPICAL TREATMENT OF NON-MICROORGANISM-CAUSED INFLAMMATORY SKIN AND MUCOUS-MEMBRANE DISEASES Bläss, Markus (DE) 2020-07-08 EP claimed
EP-3328409-A1 COMPOSITION FOR THE INCREASE OF HUMORAL SECRETION Metis Healthcare S.r.L. (IT) 2018-06-06 EP claimed
WO-2017021816-A1 COMPOSITION FOR THE INCREASE OF HUMORAL SECRETION METIS HEALTHCARE S.R.L. (IT) 2017-02-09 WO claimed
EP-2612147-B1 AUTOMATIC IMMUNOASSAY FOR BIOGENIC AMINES KELLNER KARL-HEINZ (DE) 2016-03-30 EP claimed
EP-4097145-B1 REDUCTION OF ADSORPTION LEUKOCARE AG (DE) 2026-01-28 EP disclosed
US-12350375-B2 Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy LEUKOCARE AG (DE) 2025-07-08 US disclosed
WO-2024105922-A1 COMPOSITION FOR ANTI-OBESITY, BODY FAT REDUCTION OR FAT METABOLISM PROMOTION USES プレミアアンチエイジング株式会社 2024-05-23 WO disclosed
US-20230225939-A1 MEANS AND METHODS OF STERILIZATION OF BIOFUNCTIONAL COMPOSITIONS LEUKOCARE AG (DE) 2023-07-20 US disclosed
EP-3511336-B1 METHOD FOR PREVENTING THE UNFOLDING OF A (POLY)PEPTIDE AND/OR INDUCING THE (RE-)FOLDING OF A (POLY)PEPTIDE LEUKOCARE AG (DE) 2023-06-21 EP disclosed
US-20230041240-A1 Reduction of Adsorption LEUKOCARE AG (DE) 2023-02-09 US disclosed
US-11564865-B2 Means and methods of sterilization of biofunctional compositions LEUKOCARE AG (DE) 2023-01-31 US disclosed
US-20220395521-A1 MICROBIOME REGULATORS AND RELATED USES THEREOF KALEIDO BIOSCIENCES, INC. (US) 2022-12-15 US disclosed
WO-2010104384-A1 NUTRITIONAL COMPOSITION INDUCING A POSTPRANDIAL ENDOCRINE RESPONSE N.V. NUTRICIA (NL) 2010-09-16 WO disclosed
US-20080171095-A1 Carnosine-related compounds for preventing and treating impaired neurovascular blood flow MICHIGAN STATE UNIVERSITY 2008-07-17 US disclosed
EP-1883406-A2 COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE Natural Alternatives International (US) 2008-02-06 EP disclosed
WO-2007073398-A2 COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE NATURAL ALTERNATIVES INTERNATIONAL (US) 2007-06-28 WO disclosed
EP-0825871-B1 PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS WITH ANTIOXIDANT ACTIVITY CONTAINING CARNOSINE OR DERIVATIVES AND BRANCHED AMINO ACIDS FARMILA FARMA MILANO (IT) 2001-08-22 EP disclosed
US-5866537-A SYNERGISTIC MIXTURE FARMILA-FARMACEUTICI MILANO S.R.L. 1999-02-02 US disclosed
EP-0825871-A1 PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS WITH ANTIOXIDANT ACTIVITY CONTAINING CARNOSINE OR DERIVATIVES AND BRANCHED AMINO ACIDS Farmila Farmaceutici Milano S.p.A. (IT) 1998-03-04 EP disclosed
WO-1996036348-A1 PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS WITH ANTIOXIDANT ACTIVITY CONTAINING CARNOSINE OR DERIVATIVES AND BRANCHED AMINO ACIDS FARMILA-FARMACEUTICI MILANO S.R.L. (IT) 1996-11-21 WO disclosed